Carglumic Acid Tablet, For Suspension
Product Images NDC 68475-006

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carglumic Acid (NDC 68475-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 01)

1 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 01)
Dosage and administration information for a drug called Carglumic Acid can be found in the package insert. The drug is manufactured in India and the container should be tightly closed to prevent moisture. The expiration date is labeled on the container and one should not use the drug after its expiration. The drug should be discarded a month after the first opening, and the date of first opening should be labeled on the container. The drug should be stored at a temperature between 20° to 25°C (68°F to 77°F) with excursions allowed between 15°C and 30°C (59°F and 86°F). This drug should be kept out of the reach of children.*
FDA Label Image

2 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 02)

2 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 02)
This is an instruction sheet for Carglumic acid tablets, available as oral suspension of 200mg. These tablets should be dispersed in water and should not be swallowed whole or crushed. The tablets should be kept tightly closed to prevent moisture. The tablets should be stored at room temperature between 15°C and 30°C. It is important to discard them after one month of opening. Additionally, the sheet reminds the user to keep medications out of reach of children. The text also includes the product code (NDC 68475-006-01) and manufacturer information. However, the text also includes some random characters and misspelled words, which might have resulted from an scanning error.*
FDA Label Image

3 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 03)

3 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 03)
The text provides information about Dosage and Administration, and includes the National Drug Code and a code number. It instructs the user to consult the package insert for dosage information and to keep the container tightly closed to protect from moisture after opening. The medication, Carglumic Acid tablets, were manufactured in India for Navinta LLC in Ewing, NJ. The tablet container must be discarded after one month of first opening, and the date of first opening must be noted on the carton and container. The medication should be stored between 20 to 25°C (68°F to 77°F) and kept out of reach of children.*
FDA Label Image

4 (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 04)

FDA Label Image

Image (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 195 1)

FDA Label Image

Image (99df9818 313d 42a4 A5c3 Bfa1d3b6f638 220 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.